Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro
Abstract Background Pain relief remains a major subject of inadequately met need of patients. Therapeutic agents designed to treat pain and inflammation so far have low to moderate efficiencies with significant untoward side effects. FAAH-1 has been proposed as a promising target for the discovery o...
Saved in:
Main Authors: | Julius T. Dongdem (Author), Gideon K. Helegbe (Author), Kwame Opare-Asamoah (Author), Cletus A. Wezena (Author), Augustine Ocloo (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
by: Naresh Sunduru, et al.
Published: (2017) -
A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
by: Dale Deutsch
Published: (2016) -
Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity
by: Rief Winfried, et al.
Published: (2010) -
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
by: Alessandro Deplano, et al.
Published: (2019) -
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen
by: Alessandro Deplano, et al.
Published: (2020)